Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cashflow Statement

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,189 Cr₹1,114 Cr₹745 Cr₹909 Cr₹900 Cr
Adjustment ₹112 Cr₹83 Cr₹131 Cr₹92 Cr₹115 Cr
Changes In working Capital ₹179 Cr₹-100 Cr₹67 Cr₹-200 Cr₹-209 Cr
Cash Flow after changes in Working Capital ₹1,480 Cr₹1,097 Cr₹943 Cr₹801 Cr₹807 Cr
Cash Flow from Operating Activities ₹1,157 Cr₹785 Cr₹792 Cr₹562 Cr₹576 Cr
Cash Flow from Investing Activities ₹-377 Cr₹65 Cr₹-560 Cr₹-74 Cr₹-282 Cr
Cash Flow from Financing Activities ₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr₹-318 Cr
Net Cash Inflow / Outflow ₹47 Cr₹-201 Cr₹124 Cr₹28 Cr₹-24 Cr
Opening Cash & Cash Equivalents ₹129 Cr₹330 Cr₹206 Cr₹178 Cr₹202 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹177 Cr₹129 Cr₹331 Cr₹205 Cr₹178 Cr

Compare Cashflow Statement of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹36,273.5 Cr -1.6% -1.9% 14.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-1.6%

-1.9%

14.4%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses